Clinical Trials Directory

Trials / Completed

CompletedNCT01222598

A Study of Minirin Melt in Patients With Nocturia

Minirin Melt Tolerance With Nocturia in the Common Practice Conditions in Czech Republic

Status
Completed
Phase
Study type
Observational
Enrollment
588 (actual)
Sponsor
Ferring Pharmaceuticals · Industry
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Not accepted

Summary

This is a confirmation of safety profile for Minirin Melt in clinical practice.

Conditions

Timeline

Start date
2008-09-01
Primary completion
2010-12-01
Completion
2011-03-01
First posted
2010-10-18
Last updated
2012-10-08

Locations

37 sites across 1 country: Czechia

Source: ClinicalTrials.gov record NCT01222598. Inclusion in this directory is not an endorsement.

A Study of Minirin Melt in Patients With Nocturia (NCT01222598) · Clinical Trials Directory